|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 104, 1597-1601, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
JD Lehman, C Dyke, A Abd-Elfattah, T Yeh Jr, M Ding, A Ezrin and AS Wechsler
Covalent linkage of polyethylene glycol to superoxide dismutase prolongs
the serum half-life of the enzyme and may facilitate intracellular access.
We tested the myocardial protective effect of polyethylene glycol
superoxide dismutase administered once, 24 hours before ischemia. Because
hearts were studied ex vivo in a crystalloid perfused system,
cardioprotection could be ascribed to intramyocardial or membrane-bound
polyethylene glycol superoxide dismutase accumulation. Thirty isolated
rabbit hearts from the four following groups were studied: (1) control:
untreated rabbits (n = 7); (2) PEG- control: 24-hour intravenous
preinfusion of methoxypolyethylene glycol 5000 (5 mg/kg) to examine the
effect of polyethylene glycol alone, without conjugation to superoxide
dismutase (n = 8); (3) PEG-SOD 10,000: 24-hour preinfusion of polyethylene
glycol superoxide dismutase (10,000 U/kg) (n = 8); (4) PEG-SOD 30,000:
24-hour preinfusion of polyethylene glycol superoxide dismutase (30,000
U/kg) (n = 7). After measurement of baseline function with use of an
intraventricular balloon, hearts were subjected to normothermic ischemia
until a 4 mm Hg rise in intracavitary pressure was observed. Function was
assessed at 15-minute intervals throughout reperfusion and expressed as
percent return of developed pressure. After 60 minutes of reperfusion,
recovery of function was greater for the PEG-SOD 30,000 group (85.6% +/-
2.6%) when compared with either the untreated or PEG-control group (68.9%
+/- 2.3% and 71.4% +/- 2.0%, respectively). A similar difference was seen
throughout reperfusion. Although an improved return of function was shown
in the lower dose PEG-SOD 10,000 group, the margin of difference when
compared with any of the control groups was determined to be insignificant
at all times of reperfusion and at 60 minutes (75.9% +/- 3.2%). These data
demonstrate that high, but not low, doses of polyethylene glycol superoxide
dismutase significantly reduce reperfusion injury when administered 24
hours before initiation of global ischemia. Moreover, since the perfusate
was superoxide dismutase free, this effect was most likely intramyocardial
or membrane bound and therefore might be added to protection afforded by
circulating superoxide dismutase.
ARTICLES
Polyethylene glycol-conjugated superoxide dismutase attenuates reperfusion injury when administered twenty-four hours before ischemia
Department of Surgery, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298.
This article has been cited by other articles:
![]() |
J. P. Slater, M. M.R. Amirhamzeh, O. J. Yano, A. S. Shah, J. P. Starr, R. J. Kaplon, W. Burfeind, P. Pepino, R. E. Michler, E. A. Rose, et al. Discriminating Between Preservation and Reperfusion Injury in Human Cardiac Allografts Using Heart Weight and Left Ventricular Mass Circulation, November 1, 1995; 92(9): 223 - 227. [Abstract] [Full Text] |
||||
![]() |
S. Knollema, W. Aukema, H. Hom, J. Korf, and G. J. Ter Horst L-Deprenyl Reduces Brain Damage in Rats Exposed to Transient Hypoxia-Ischemia Stroke, October 1, 1995; 26(10): 1883 - 1887. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |